Researchers find novel predictor for MDS progression risk
Researchers at Moffitt Cancer Center and colleagues have discovered that changes in the physical characteristics of the effector memory regulatory T cell can predict the progression risk of myelodysplastic syndromes (MDS) ...
Immunology
Sep 13, 2012 |
not rated yet |
0
|
Improved diagnostic test benefits children with acute myeloid leukemia
Early treatment response is a powerful predictor of long-term outcome for young patients with acute myeloid leukemia (AML). The information can help physicians decide whether a more intensive approach is needed. Research ...
Cancer
Sep 10, 2012 |
not rated yet |
0
Possible new therapy for the treatment of myeloma
(Medical Xpress)—Research from Karolinska Institutet shows that sorafenib, a drug used for advanced cancer of the kidneys and liver, could also be effective against multiple myeloma. The disease is one of the more common ...
Cancer
Sep 05, 2012 |
not rated yet |
0
|
Has osteoporosis treatment failed when a fracture occurs?
The International Osteoporosis Foundation (IOF) has published practical guidelines to assist clinicians in assessing treatment efficacy in patients who experience a fracture while on medication for osteoporosis.
Diseases, Conditions, Syndromes
Aug 31, 2012 |
not rated yet |
1
Heart separation device improves 3 year outcomes in heart failure patients
A novel non-invasive device which separates healthy and damaged heart muscle and restores ventricle function improves 3 year outcomes in patients with ischemic heart failure, according to research presented at the ESC Congress ...
Cardiology
Aug 27, 2012 |
not rated yet |
0
Researchers develop new approach to treat acute liver failure
Acute liver failure is a life-threatening disease, characterized by a sudden, massive death of liver cells. Unfortunately, few treatment options exist, especially for advanced-stage liver failure. As a last resort a liver ...
Diseases, Conditions, Syndromes
Aug 03, 2012 |
not rated yet |
0
Short/long-term analyses deem etanercept safe for psoriasis
(HealthDay) -- Etanercept treatment is well tolerated for psoriasis, with no indication of dose-related or cumulative toxicity in short- or long-term analyses, according to a study published in the August ...
Diseases, Conditions, Syndromes
Jul 29, 2012 |
not rated yet |
0
Many more elderly people could benefit from drugs to prevent heart disease
More patients aged 75 and over should be prescribed drugs to help lower their risk of cardiovascular disease, a study published today in the British Medical Journal suggests.
Cardiology
Jul 12, 2012 |
not rated yet |
0
Prostate cancer treatment regret is 52 percent higher in men with cardiovascular disease
Prostate cancer patients with cardiovascular disease were 52 per cent more likely to regret their treatment choices than men without problems with their heart or veins, according to a study published in the July issue of ...
Cardiology
Jul 02, 2012 |
not rated yet |
0
Rheumatoid arthritis takes high toll in unemployment, early death
In the realm of deadly and disabling diseases, conditions such as cancer and Alzheimer's seem to attract the most media attention. But there are others that take a similarly high toll, and rheumatoid arthritis is one of them, ...
Arthritis & Rheumatism
Jul 02, 2012 |
not rated yet |
0
New once-daily 'Quad' pill for HIV is safe, effective alternative to traditional antiretroviral regimens
A new once-daily pill combining three antiretrovirals and a booster molecule is a safe and effective alternative to two widely used drug regimens for newly diagnosed HIV-positive adults who have had no previous treatment. ...
HIV & AIDS
Jun 28, 2012 |
not rated yet |
0
Study finds significantly higher rate of untreated kidney failure among older adults
In a study that included nearly 2 millions adults in Canada, the rate of progression to untreated kidney failure was considerably higher among older adults, compared to younger individuals, according to a study in the June ...
Diseases, Conditions, Syndromes
Jun 19, 2012 |
not rated yet |
0
Atrial fibrillation: Flec-SL trial proves efficacy of short-term antiarrhythmic drug treatment
Atrial fibrillation (AF) is the most frequently sustained arrhythmia of the heart. It affects several million people in Europe. AF causes a loss of contraction in the atria and gives rise to heart failure. Moreover, it is ...
Cardiology
Jun 18, 2012 |
not rated yet |
0
Haematopoietic stem cell transplantation increases survival in systemic sclerosis patients
Initial results from an international, investigator-initiated, open label phase III trial were presented at EULAR 2012, the Annual Congress of the European League Against Rheumatism. Data indicate that haematopoietic stem ...
Arthritis & Rheumatism
Jun 07, 2012 |
not rated yet |
0
Intravenous kidney cell transplant experiments raise hope for future human kidney failure treatments
Indiana University School of Medicine scientists have successfully transplanted primary kidney cells intravenously to treat renal failure in rats, pointing the way to a possible future alternative to kidney ...
Other
May 31, 2012 |
not rated yet |
0
